1. Clinical Overview
A fixed-dose topical combination therapy containing a moderate-potency corticosteroid (Beclometasone dipropionate) and a broad-spectrum imidazole antifungal (Clotrimazole). It is primarily indicated for the treatment of inflammatory dermatoses complicated by or at high risk of superficial fungal infections, particularly in the humid Indian climate. The combination provides synergistic anti-inflammatory, antipruritic, and antifungal effects, addressing both the underlying inflammation and secondary or concomitant fungal overgrowth.
| Onset | Duration | Bioavailability |
|---|---|---|
| Antipruritic effect: 3-6 hours. Anti-inflammatory effect: 24-48 hours. Antifungal symptom relief: 24-72 hours. | Topical effect lasts 12-24 hours post-application, allowing for once or twice-daily dosing. | Topical systemic absorption is low (<5%) on intact skin but increases significantly on inflamed, broken skin, or under occlusion. |
2. Mechanism of Action
Beclometasone: A synthetic glucocorticoid receptor agonist. It diffuses across cell membranes, binds to cytoplasmic glucocorticoid receptors, and translocates to the nucleus. This complex modulates gene transcription, leading to the synthesis of anti-inflammatory proteins (lipocortin) and inhibition of pro-inflammatory mediators (cytokines, leukotrienes, prostaglandins). It also causes vasoconstriction, reducing erythema and edema. Clotrimazole: Inhibits the fungal cytochrome P450-dependent enzyme lanosterol 14-α-demethylase. This disrupts the conversion of lanosterol to ergosterol, a critical component of the fungal cell membrane. Accumulation of toxic methylated sterols leads to increased membrane permeability, leakage of cellular components, and fungal cell death.
3. Indications & Uses
- Dermatophytosis (Tinea corporis, Tinea cruris, Tinea pedis) with significant inflammation and itching
- Cutaneous Candidiasis (intertrigo) with inflammatory component
- Seborrheic Dermatitis (non-facial, severe cases) with suspected Malassezia overgrowth
- Eczematoid Dermatitis complicated by secondary fungal infection
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected and immediately surrounding area once or twice daily. Duration: Typically 1-2 weeks for fungal infections, up to 4 weeks for severe inflammatory conditions. Do not exceed 4 weeks without re-evaluation.
Administration: 1. Wash and dry the affected area thoroughly. 2. Take a small amount (pea-sized for an area the size of the palm). 3. Gently rub in a thin layer until absorbed. 4. Do not bandage, wrap, or occlude the area unless specifically directed by a physician. 5. Wash hands after application unless hands are the treatment site. Avoid contact with eyes, nose, mouth, and broken skin.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation (initial application)
- Dryness of skin
- Erythema
- Itching at application site
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids (e.g., Betamethasone, Mometasone) | Additive risk of local and systemic adverse effects, skin atrophy. | Major |
| Systemic CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) | May inhibit metabolism of systemically absorbed beclometasone, increasing risk of steroid side effects. | Moderate |
| Immunosuppressants (e.g., Tacrolimus, Pimecrolimus - topical) | Concomitant use may increase risk of skin infection; sequential use should be monitored. | Moderate |
7. Patient Counselling
- DO use exactly as prescribed by the doctor for the prescribed duration.
- DO wash and dry the area thoroughly before application.
- DO use a thin layer; more is not better.
- DON'T apply to the face, groin, or armpits unless specifically instructed.
- DON'T cover the area with tight dressings or bandages (occlusion).
- DON'T share your medication with others, even if symptoms seem similar.
- DON'T use for longer than 4 weeks without consulting your doctor.
- DO wash your hands after application.
8. Toxicology & Storage
Overdose: Topical overdose: Exaggerated local effects - severe skin atrophy, striae, telangiectasia, ulceration, HPA axis suppression (symptoms: fatigue, weakness, nausea, hypotension, hyperglycemia). Acute oral ingestion of large amounts: Gastrointestinal upset (nausea, vomiting).
Storage: Store at room temperature (15-25°C), in a cool, dry place. Protect from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.